Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Voya Emerging Markets High Income Dividend Equity Fund | IHD | Nov 27, 2024 | 5.18 | +0.39 |
Voya Financial | VOYA | Nov 27, 2024 | 82.93 | +0.62 |
Voya Financial B Pref | VOYA-B | Nov 27, 2024 | 24.97 | +0.29 |
Voya Global Advantage And Premium Opportunity Fund | IGA | Nov 27, 2024 | 9.69 | 0.00 |
Voya Global Equity Dividend And Premium Opportunity Fund | IGD | Nov 27, 2024 | 5.62 | +0.45 |
Voya Infrastructure Industrials And Materials Fund | IDE | Nov 27, 2024 | 11.02 | +0.46 |
Voyager Acquisition | VACHU | Nov 27, 2024 | 10.08 | 0.00 |
Voyager Acquisition | VACH | Nov 27, 2024 | 10.02 | 0.00 |
Voyager Therapeutics | VYGR | Nov 27, 2024 | 5.78 | +1.94 |
Vrdo Tax-Free Weekly Powershares | PVI | Nov 27, 2024 | 24.79 | +0.02 |
Vroom | VRM | Nov 27, 2024 | 5.30 | +5.37 |
VS Media | VSME | Nov 27, 2024 | 1.19 | +6.25 |
VSE | VSEC | Nov 27, 2024 | 114.99 | -1.09 |
VSee Health | VSEE | Nov 27, 2024 | 1.93 | -4.93 |
VTEX A | VTEX | Nov 27, 2024 | 6.31 | -2.17 |
vTv Therapeutics A | VTVT | Nov 27, 2024 | 15.51 | +0.58 |
Vulcan Materials | VMC | Nov 27, 2024 | 286.39 | -0.70 |
Vuzix | VUZI | Nov 27, 2024 | 2.13 | +8.12 |
Vyne Therapeutics | VYNE | Nov 27, 2024 | 2.95 | +2.08 |
W&T Offshore | WTI | Nov 27, 2024 | 1.91 | 0.00 |
W. P. Carey REIT | WPC | Nov 27, 2024 | 57.51 | +1.18 |
W.R. Berkley | WRB | Nov 27, 2024 | 64.94 | +0.95 |
W.W. Grainger | GWW | Nov 27, 2024 | 1 205.87 | -0.94 |
Wabash National | WNC | Nov 27, 2024 | 19.61 | +0.46 |
WaFd | WAFD | Nov 27, 2024 | 37.11 | -0.16 |
Wafd Pref | WAFDP | Nov 27, 2024 | 17.51 | +0.98 |
Wag! Group | PET | Nov 27, 2024 | 0.21 | +4.22 |
Wah Fu Education Group | WAFU | Nov 27, 2024 | 1.72 | +6.83 |
Waldencast | WALD | Nov 27, 2024 | 3.29 | -0.30 |
Walgreens Boots Alliance | WBA | Nov 27, 2024 | 9.06 | +3.78 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.